Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 6
2007 2
2008 8
2009 10
2010 17
2011 16
2012 21
2013 21
2014 31
2015 18
2016 25
2017 24
2018 17
2019 12
2020 26
2021 31
2022 27
2023 35
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
Page 1
Preparation and application of pH-responsive drug delivery systems.
Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X, Gu Z, Luo K. Ding H, et al. Among authors: gu z. J Control Release. 2022 Aug;348:206-238. doi: 10.1016/j.jconrel.2022.05.056. Epub 2022 Jun 8. J Control Release. 2022. PMID: 35660634 Review.
Stimuli-activatable nanomedicine meets cancer theranostics.
Li H, Feng Y, Luo Q, Li Z, Li X, Gan H, Gu Z, Gong Q, Luo K. Li H, et al. Among authors: gu z. Theranostics. 2023 Oct 2;13(15):5386-5417. doi: 10.7150/thno.87854. eCollection 2023. Theranostics. 2023. PMID: 37908735 Free PMC article. Review.
Nanomedicine Combats Drug Resistance in Lung Cancer.
Zheng X, Song X, Zhu G, Pan D, Li H, Hu J, Xiao K, Gong Q, Gu Z, Luo K, Li W. Zheng X, et al. Among authors: gu z. Adv Mater. 2024 Jan;36(3):e2308977. doi: 10.1002/adma.202308977. Epub 2023 Nov 27. Adv Mater. 2024. PMID: 37968865 Review.
Diverse Applications of Nanomedicine.
Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen X, Cheng Z, Cui D, Du J, Dullin C, Escudero A, Feliu N, Gao M, George M, Gogotsi Y, Grünweller A, Gu Z, Halas NJ, Hampp N, Hartmann RK, Hersam MC, Hunziker P, Jian J, Jiang X, Jungebluth P, Kadhiresan P, Kataoka K, Khademhosseini A, Kopeček J, Kotov NA, Krug HF, Lee DS, Lehr CM, Leong KW, Liang XJ, Ling Lim M, Liz-Marzán LM, Ma X, Macchiarini P, Meng H, Möhwald H, Mulvaney P, Nel AE, Nie S, Nordlander P, Okano T, Oliveira J, Park TH, Penner RM, Prato M, Puntes V, Rotello VM, Samarakoon A, Schaak RE, Shen Y, Sjöqvist S, Skirtach AG, Soliman MG, Stevens MM, Sung HW, Tang BZ, Tietze R, Udugama BN, VanEpps JS, Weil T, Weiss PS, Willner I, Wu Y, Yang L, Yue Z, Zhang Q, Zhang Q, Zhang XE, Zhao Y, Zhou X, Parak WJ. Pelaz B, et al. Among authors: gu z. ACS Nano. 2017 Mar 28;11(3):2313-2381. doi: 10.1021/acsnano.6b06040. Epub 2017 Mar 14. ACS Nano. 2017. PMID: 28290206 Free PMC article. Review.
Polysaccharide-based nanomedicines for cancer immunotherapy: A review.
Zeng Y, Xiang Y, Sheng R, Tomás H, Rodrigues J, Gu Z, Zhang H, Gong Q, Luo K. Zeng Y, et al. Among authors: gu z. Bioact Mater. 2021 Mar 18;6(10):3358-3382. doi: 10.1016/j.bioactmat.2021.03.008. eCollection 2021 Oct. Bioact Mater. 2021. PMID: 33817416 Free PMC article. Review.
308 results